Regulators are seeking input on a contractor to help it shield drug manufacturers from giving duplicate 340B discounts and new [...] …
Year: 2023
SPONSORED CONTENT
To ensure compliance, maximize savings, and streamline operations, consider these five best practices.
1. Proficiency in Data Management
To effectively manage your 340B program, it’s crucial to comprehend how data is created, stored, and transmitted to your Third-Party Administrator (TPA). Typically,
…
Drug manufacturer Teva this week added a drug to the hospital contract pharmacy restrictions it first implemented in June. The [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
Witnesses recently told a U.S. House subcommittee that Congress should cut Medicare payments for 340B drugs. The House Energy and [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
A final rule to implement the 340B administrative dispute resolution (ADR) process arrived this week at the last stage of [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
A total of 16 covered entities (CEs) owe repayment to drugmakers, five more than reported a month ago, according to [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
More than 400 hospitals risk losing 340B eligibility if Congress does not extend exemptions authorized during the public health emergency [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
SPONSORED CONTENT
If you have one or more agreements with 340B Third Party Administrator(s) (TPA) to manage your contract pharmacy arrangements, how much do you know about those contracts and associated fees? Chances are, you don’t know the answers to all the questions that follow. Be
…
The majority of 340B disproportionate share hospitals (DSH) provide charity care at lower rates than the national hospital average, found [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
Timelines for manufacturers to provide new Medicare “maximum fair prices” (MFPs) and 340B ceiling prices on drugs are misaligned, risking [...] …
